ERAVACYCLINE

SynDRA canonical compound SYN0028739 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx
Mechanism of action	antibacterial \| bacterial 30s ribosomal subunit inhibitor
Indication	gram-positive bacterial infections
Disease area	infectious disease

Mechanisms of action (all sources)

eravacycline dihydrochloride
xerava
TP-434
Eravaciclina
Tp-434
Xerava
TP-038
TP-120
TP-170
TP-221
TP-271
TP-787
Tetracycline analogs (bacterial infection), Tetraphase Pharmaceuticals
Tetracycline derivatives (bacterial infection), Tetraphase Pharmaceuticals
Fluorocycline antibiotic (oral, bacterial infection), Tetraphase Pharmaceuticals
Tetracycline analogs (iv, antibiotic), Tetraphase Pharmaceuticals
TP-434 (oral, multidrug-resistant bacterial infections)
TP-434 (oral, multidrug-resistant bacterial infections), Tetraphase Pharmaceuticals
UNII-Y6IUM7395Q
Y6IUM7395Q
(S)-N-((5aR,6aS,7S,10aS)-9-carbamoyl-7-(dimethylamino)-4-fluoro-1,8,10a,11-tetrahydroxy-10,12-dioxo-5,5a,6,6a,7,10,10a,12-octahydrotetracen-2-yl)-1-methylpyrrolidine-2-carboxamide
(2S)-N-((5aR,6aS,7S,10aR)-9-carbamoyl-7-(dimethylamino)-4-fluoro-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl)-1-methylpyrrolidine-2-carboxamide
(2S)-N-[(5aR,6aS,7S,10aR)-9-carbamoyl-7-(dimethylamino)-4-fluoro-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-methylpyrrolidine-2-carboxamide
CHEMBL2057236
SCHEMBL13397803
GTPL11013
TP271
DB15040
Eravacycline dihydrochloride
RefChem:933224
Eravacycline [USAN]
Eravacycline [USAN:INN]
eravaciclina
TP434
UNII-07896928ZC
YQM
TP434;Eravacycline
ERAVACYCLINE [MI]